Former U.S. President Joe Biden, aged 82, has been diagnosed with an aggressive form of prostate cancer that has metastasized to his bones. The diagnosis followed the discovery of a prostate nodule during a routine physical examination after he reported increasing urinary symptoms. A biopsy confirmed a Gleason score of 9 (Grade Group 5), indicating a high-grade, fast-growing cancer. Despite the severity, the cancer is hormone-sensitive, allowing for potential management through hormone-based therapies.

Biden and his family are currently reviewing treatment options with his medical team. Hormone-sensitive prostate cancers respond to therapies that lower testosterone levels, which can slow disease progression. While metastatic prostate cancer is generally not curable, advancements in treatment have improved outcomes, with patients often living several years post-diagnosis, depending on various factors.

The news has prompted an outpouring of support from across the political spectrum. Vice President Kamala Harris described Biden as “a fighter” and expressed confidence in his resilience. Former President Donald Trump also extended his well-wishes for a speedy recovery.

Biden’s diagnosis brings renewed attention to prostate cancer, one of the most common cancers among men. The disease often progresses silently, with symptoms appearing in advanced stages, underscoring the importance of regular screenings for early detection.

For more stories and insights, visit It’s On

Instagram:@itson.ie

TikTok videos and information:@itson.ie